Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Eur J Gynaecol Oncol ; 32(4): 455-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21941978

RESUMO

PURPOSE OF INVESTIGATION: A rare case of increasing CA 125 and CA 19-9 levels increasing in a woman with adenomyoma is described. METHODS: A 39-year-old nullipara woman with CA 125 = 1,796 U/ml and CA 19-9 = 177 U/ml was submitted to abdominal and pelvic MRI, gastric endoscopy, colonoscopy, hysteroscopy, pelvic Doppler and PET scan. None of the exams revealed any apparent malignant disease. RESULTS: Six months of gonadotropin releasing hormone agonist treatment reduced CA 125 and CA 19-9 levels. However, after contraceptive pill use the markers were again elevated, and a laparoscopic hysterectomy was performed, and normal CA 125 and CA 19-9 levels were achieved. CONCLUSIONS: Adenomyoma may be associated with high levels of CA 125 and CA 19-9.


Assuntos
Adenomioma/diagnóstico , Adenomioma/terapia , Antígeno Ca-125/sangue , Antígeno CA-19-9/sangue , Neoplasias Ovarianas/diagnóstico , Neoplasias Ovarianas/terapia , Adenomioma/sangue , Adenomioma/tratamento farmacológico , Adenomioma/cirurgia , Adulto , Relação Dose-Resposta a Droga , Feminino , Hormônio Liberador de Gonadotropina/agonistas , Humanos , Neoplasias Ovarianas/sangue , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...